Flexion Therapeutics' (FLXN) FX006 Granted FDA Fast-Track Designation
Tweet Send to a Friend
Flexion Therapeutics (NASDAQ: FLXN) announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for FX006 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE